FDA Inspection 1009619 — Strides Pharma, Inc.

Strides Pharma, Inc. — FEI 2434223

The FDA completed an inspection of Strides Pharma, Inc. on March 16, 2017 in Chestnut Ridge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chestnut Ridge, NY (United States)